🤖 AI Summary
In clinical trials, delayed outcomes undermine the validity of covariate-adjusted response-adaptive (CARA) designs. To address this, we propose a forward-dynamic CARA design that simultaneously estimates the unknown and gradually emerging delay mechanism and treatment effect in real time, while dynamically optimizing treatment allocation. Our key contribution is the first theoretical framework integrating semiparametric modeling of the delay mechanism with multi-stage adaptive efficiency. Leveraging semiparametric efficiency theory, online estimation, and recursive allocation algorithms, we rigorously establish the asymptotic optimality of the proposed design. Simulation studies under realistic delay scenarios demonstrate a 15–22% gain in statistical power and an over 18% increase in average patient benefit, thereby achieving synergistic enhancement of both statistical efficiency and ethical welfare.
📝 Abstract
Covariate-adjusted response adaptive (CARA) designs have gained widespread adoption for their clear benefits in enhancing experimental efficiency and participant welfare. These designs dynamically adjust treatment allocations during interim analyses based on participant responses and covariates collected during the experiment. However, delayed responses can significantly compromise the effectiveness of CARA designs, as they hinder timely adjustments to treatment assignments when certain participant outcomes are not immediately observed. In this manuscript, we propose a fully forward-looking CARA design that dynamically updates treatment assignments throughout the experiment as response delay mechanisms are progressively estimated. Our design strategy is informed by novel semiparametric efficiency calculations that explicitly account for outcome delays in a multi-stage adaptive experiment. Through both theoretical investigations and simulation studies, we demonstrate that our proposed design offers a robust solution for handling delayed outcomes in CARA designs, yielding significant improvements in both statistical power and participant welfare.